ApprovalTrail

Drug · DIN 02371650

DOCUSEN

Authorized, not yet reported as sold

Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.

Status Approved since August 8, 2011.
Drug Identification Number (DIN)
02371650
Company (DIN owner)
JAMP Pharma CorporationBoucherville, Quebec, Canada
Schedule
Non-prescription drugs
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Senna glycosides, combinations A06AB56
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
SENNOSIDES8.6 MG
DOCUSATE SODIUM100 MG